Officials said the funding will be used to build on the company’s existing surveillance solutions, to grow the company’s internal customer service and clinical adoption teams and to support ongoing research and development.
Hospitals and health systems that employ PeraHealth products include Yale New Haven (Conn.) Health System, Children’s Hospital of Philadelphia and New York City-based Memorial Sloan Kettering Cancer Center.
“We’ve made significant strides in helping improve outcomes and lower costs with our current customers, but we’ve only scratched the surface and know we can broaden our solutions to help more health systems save patients’ lives. This funding provides PeraHealth with the resources to continue to transform healthcare through the intelligent use of data and grow our product portfolio,” said Stephanie Alexander, CEO of PeraHealth.
More articles on healthcare finance:
Moody’s affirms The Christ Hospital’s ‘A3’ rating
Moody’s affirms DCH Health System’s ‘A2’ rating
Moody’s affirms Aurora Health Care’s ‘A2’ rating
